Health In Tech, Inc. (HIT) is a healthcare technology company offering an AI-enabled insurance technology platform. The company is registered to resell up to 5,600,000 shares of its Class A common stock, originally acquired in a private investment in public equity financing (PIPE Offering) in March 2026. The proceeds from the resale will be received by the selling stockholders, not HIT.
The prospectus highlights several risks associated with the offering, including potential adverse effects on the market price of HIT's Class A common stock due to the resale of a substantial number of shares, and the possibility of increased volatility and downward pressure on the trading price. Additionally, the prospectus discloses risks related to HIT's HI Card platform, which has not generated revenue and its development is temporarily paused.
The document also provides detailed information about HIT's capital structure, including three classes of stock: Class A common stock, Class B common stock, and Series A preferred stock, each with specific rights and preferences. The prospectus outlines the authorized capitalization, voting rights, dividend rights, liquidation rights, and conversion rights for each class of stock.
Furthermore, it explains the plan of distribution, which allows the selling stockholders to resell the shares of Class A common stock directly or through underwriters, broker-dealers, or agents, using various methods such as ordinary brokerage transactions, block trades, and privately negotiated transactions. The prospectus emphasizes that HIT will not receive any proceeds from the sale of these shares and will bear all other costs and expenses incurred in the registration process.
